LYMPHOPENIA

Clinical trials for LYMPHOPENIA explained in plain language.

Never miss a new study

Get alerted when new LYMPHOPENIA trials appear

Sign up with your email to follow new studies for LYMPHOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1

Experimental combo aims to cut deaths in severe pneumonia patients

Disease control Terminated

This study was designed to test whether adding two experimental agents (nogapendekin alfa inbakicept and iNKT cells) to standard care could lower the risk of death within 28 days in critically ill adults with severe community-acquired pneumonia, with or without sepsis or acute re…

Matched conditions: LYMPHOPENIA

Phase: PHASE3 • Sponsor: ImmunityBio, Inc. • Aim: Disease control

Last updated May 15, 2026 11:54 UTC

LYMPHOPENIA

Get alerted when new LYMPHOPENIA trials appear

Experimental combo aims to cut deaths in severe pneumonia patients